Dual Antithrombotic Therapy Is Safe and Effective in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Updated Systematic Review and Meta-Analysis

被引：0
|
作者：
Bakar, Shahrukh [1 ]
Shere, Mahvash [2 ]
Ko, Dennis [3 ]
Martin, Janet [4 ]
Garg, Pallav [4 ]
机构：
[1] Western Univ, London, ON, Canada
[2] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[3] Inst Clin Evaluat Sci, Toronto, ON, Canada
[4] London Hlth Sci Ctr, London, ON, Canada
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2019年 / 74卷 / 13期
关键词：
D O I：
10.1016/j.jacc.2019.08.493
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT-403
引用
收藏
页码：B399 / B399
页数：1
相关论文
共 50 条
  • [21] Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome and / or undergoing percutaneous coronary intervention
    Mihajlovic, Miroslav
    Marinkovic, Milan
    Koziel, Monika
    Mujovic, Nebojsa
    Lip, Gregory Y. H.
    Potpara, Tatjana S.
    KARDIOLOGIA POLSKA, 2020, 78 (06) : 512 - 519
  • [22] Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
    Mishra, Abhishek
    Singh, Maninder
    Acker, Warren W.
    Kamboj, Sukriti
    Sporn, Daniel
    Stapleton, Dwight
    Kaluski, Edo
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2019, 74 (02) : 82 - 90
  • [23] Prognosis and antithrombotic therapy of patients with atrial fibrillation after undergoing percutaneous coronary intervention)
    Tanabe, Y.
    Tejima, T.
    Kitamura, T.
    Hojo, R.
    Komiyama, K.
    Fukamizu, S.
    Sakurada, H.
    Kobayashi, Y.
    EUROPEAN HEART JOURNAL, 2013, 34 : 353 - 354
  • [24] Utilization of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention
    Hye-Jeong Choi
    Yonghyuk Lee
    Susin Park
    Nam Kyung Je
    European Journal of Clinical Pharmacology, 2023, 79 : 541 - 551
  • [25] Meta-analysis of antithrombotic therapy with new oral anticoagulants in patients with atrial fibrillation after percutaneous coronary intervention
    Siddiqi, Rabbia
    Yamani, Naser
    Alnaimat, Saed
    Khurshid, Airnan
    Siddiqui, Sadia
    Khan, Mohammad Saud
    Khan, Safi U.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 27 (19) : 2119 - 2122
  • [26] The Optimal Antithrombotic Therapy for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention With Stenting
    Iwasaki, Yusuke
    Fukunami, Masatake
    Yamada, Takahisa
    Okuyama, Yuji
    Morita, Takasi
    Sanada, Shoji
    Furukawa, Yoshio
    Masuda, Masaharu
    Yasui, Taku
    Ueda, Hiromichi
    Okada, Takeshi
    Kawasaki, Masato
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A429 - A429
  • [27] Triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a viewpoint
    Gwyn, Jennifer C. V.
    Thomas, Mark R.
    Kirchhof, Paulus
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2017, 3 (03) : 157 - 162
  • [28] The role of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention
    Fanaroff, Alexander C.
    Lopes, Renato D.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2021, 69 : 11 - 17
  • [29] Utilization of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention
    Choi, Hye-Jeong
    Lee, Yonghyuk
    Park, Susin
    Je, Nam Kyung
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 79 (04) : 541 - 551
  • [30] Reply to: Dual vs. triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention
    Golwala, Harsh
    Cannon, Christopher P.
    Bhatt, Deepak L.
    EUROPEAN HEART JOURNAL, 2019, 40 (02) : 218 - 219
12345